Home › Chronic Myeloid Leukemia › New Jersey
Chronic Myeloid Leukemia clinical trials in New Jersey
4 studies for Chronic Myeloid Leukemia are looking for participants at sites in New Jersey.
Cities in New Jersey
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Rutgers Cancer Institute of New Jersey, New Brunswick
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Nov 10, 2026 · NCT07354074Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Englewood Hospital and Medical Center, Englewood
- Hackettstown Medical Center, Hackettstown
- Morristown Medical Center, Morristown
- and 7 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Nov 4, 2026 · NCT05334069Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1064, Hackensack
- Ascentage Investigative Site #1054, Morristown
- Ascentage Investigative Site #1098, New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Hackensack University Medical Center, Hackensack
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.